Use of Analytic Morphomics of Liver, Spleen, and Body Composition to Identify Patients at Risk for Cirrhosis

We used analytic morphomics to demonstrate that cirrhosis can be objectively quantified by using medical imaging. In a retrospective analysis of multi-protocol scans, we found that it is possible to identify patients who have cirrhosis on the basis of analyses of preexisting scans, without significant additional risk or cost.